APA (7th ed.) Citation

E, S., CE, W., M, C., J, S., H, I., S, M., . . . PD, R. (2025). Successful off-label use of elexacaftor/tezacaftor/ivacaftor in an infant with severe CF disease. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 24(5), 935. https://doi.org/10.1016/j.jcf.2025.08.006

Chicago Style (17th ed.) Citation

E, Shevill, et al. "Successful Off-label Use of Elexacaftor/tezacaftor/ivacaftor in an Infant with Severe CF Disease." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society 24, no. 5 (2025): 935. https://doi.org/10.1016/j.jcf.2025.08.006.

MLA (9th ed.) Citation

E, Shevill, et al. "Successful Off-label Use of Elexacaftor/tezacaftor/ivacaftor in an Infant with Severe CF Disease." Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, vol. 24, no. 5, 2025, p. 935, https://doi.org/10.1016/j.jcf.2025.08.006.